KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biolife Solutions (BLFS) Restructuring Costs (2019 - 2024)

Biolife Solutions (BLFS) has disclosed Restructuring Costs for 5 consecutive years, with $237000.0 as the latest value for Q1 2024.

  • On a quarterly basis, Restructuring Costs changed N/A to $237000.0 in Q1 2024 year-over-year; TTM through Mar 2024 was $238000.0, a 3300.0% increase, with the full-year FY2022 number at $18000.0, down 98.9% from a year prior.
  • Restructuring Costs was $237000.0 for Q1 2024 at Biolife Solutions, up from $1000.0 in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $998000.0 in Q1 2021 to a low of $1000.0 in Q3 2022.
  • A 4-year average of $196769.2 and a median of $179000.0 in 2020 define the central range for Restructuring Costs.
  • Peak YoY movement for Restructuring Costs: surged 1992.31% in 2021, then tumbled 99.71% in 2022.
  • Biolife Solutions' Restructuring Costs stood at $251000.0 in 2020, then crashed by 92.03% to $20000.0 in 2021, then tumbled by 95.0% to $1000.0 in 2022, then soared by 23600.0% to $237000.0 in 2024.
  • Per Business Quant, the three most recent readings for BLFS's Restructuring Costs are $237000.0 (Q1 2024), $1000.0 (Q4 2022), and $1000.0 (Q3 2022).